Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
European Journal of Pharmacology|August 9, 2002
Participation of chemical mediators other than histamine in nasal allergy signs: a study using mice lacking histamine H(1) receptorsRyoji Kayasuga, Yukio Sugimoto, Takeshi Watanabe, et al.International Immunopharmacology|July 4, 2002
Histamine H1 receptors are involved in mouse nasal allergic responses: a demonstration with H1 receptor-deficient miceRyoji Kayasuga, Yukio Sugimoto, Takeshi Watanabe, et al.Springerplus|February 10, 2015
Induction of creatine kinase release from cultured osteoclasts via the pharmacological action of aminobisphosphonatesMakoto Tanaka, Hiroshi Mori, Ryoji Kayasuga, et al.International Immunopharmacology|April 12, 2003
The role of chemical mediators in eosinophil infiltration in allergic rhinitis in miceRyoji Kayasuga, Yoshinori Iba, Maria Alejandra Hossen, et al.International Immunopharmacology|October 14, 2003
Histamine H3 receptors regulate vascular permeability changes in the skin of mast cell-deficient miceMaria Alejandra Hossen, Yoko Fujii, Yukio Sugimoto, et al.Journal of Bone and Mineral Metabolism|March 1, 2017
Minodronic acid induces morphological changes in osteoclasts at bone resorption sites and reaches a level required for antagonism of purinergic P2X2/3 receptorsMakoto Tanaka, Akihiro Hosoya, Hiroshi Mori, et al.Calcified Tissue International|June 7, 2014
Effect of intermittent and daily regimens of minodronic Acid on bone metabolism in an ovariectomized rat model of osteoporosisMakoto Tanaka, Hiroshi Mori, Ryoji Kayasuga, et al.Bone|August 9, 2008
Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopeniaMakoto Tanaka, Hiroshi Mori, Ryoji Kayasuga, et al.Bone|August 23, 2008
Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeysHiroshi Mori, Makoto Tanaka, Ryoji Kayasuga, et al.Journal of Bone and Mineral Metabolism|December 10, 2013
ONO-5334, a cathepsin K inhibitor, improves bone strength by preferentially increasing cortical bone mass in ovariectomized ratsYasuo Ochi, Hiroyuki Yamada, Hiroshi Mori, et al.Pageof 2